SARS-CoV-2 reduces TIMP3 mRNA expression in alveolar epithelial cells, that likely promotes greater ADAM17 activity in COVID-19 patients.PTEN signalling is increased after SARS-CoV-2 infection. This evidence concerns the gene TIMP3 and COVID-19.